Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02116868Completed
Randomised, single-blind trial (2 arms), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Peroperative Remifentanil consumption. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02116868.